CB Therapeutics
YC S18San Diego, US · 18 employees · 1 known investors
CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods. The company serves pharmaceutical and specialty chemical manufacturers.
Founders & leadership· Y Combinator alumni (S18)
Sher ButtinCEO & Co-founder
Jacob VoganinFounder
Investors · 1
In the news
- CB Therapeutics Secures $395M | Signalbasetrysignalbase.com · 2026
- CB Therapeutics on Republic 2023 - Kingscrowdkingscrowd.com · 2023
- CB Therapeutics - 2025 Company Profile, Funding & Competitors - Tracxntracxn.com · 2023
- CB Therapeutics and atai Life Sciences launch TryptageniXglobenewswire.com · 2022
- CB Therapeutics Closes Series A Funding - FinSMEsfinsmes.com · 2021
- CB Therapeutics Closes on Oversubscribed Series A - BioSpacebiospace.com · 2021